Form 4 for ALB Albemarle Corporation
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0000915913-25-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-27 | ALB | Anderson Melissa H. | CHRO | A - Grant | $0.00 | +5,541 | 17.9K | +45% | $0 |
| D | 2025-03-03 | 2025-02-27 | ALB | Anderson Melissa H. | CHRO | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | A | A | 5,541 | $0.00 | 17,893 | D | — | — | (F1) Restricted Stock Units vest 100% on 12/31/2026, subject to the terms of the award agreement. |
| 2 | Derivative | Stock Options | 2025-02-27 | A | A | 12,944 | $0.00 | 12,944 | D | $78.97 · — to 2035-02-27 | 12,944 Common Stock | (F3) Stock Options vest 100% and become exercisable on 12/31/2026, subject to the terms of the award agreement. |